Profile: Schering-Plough Corporation focuses on the discovery, manufacturing and distribution of medical therapies & treatments. We also sell consumer brands in the over-the-counter (OTC), foot care & sun care markets, as well as operate a global animal health business. Our Asmanex Twisthaler is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients of 4 years of age and older. Our Clarinex is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients of 2 years of age & older.
The company has revenues of USD 100-500 Million and is CE certified.